Provided by Tiger Fintech (Singapore) Pte. Ltd.

Insmed

98.73
+1.851.91%
Post-market: 98.26-0.5270-0.53%19:39 EDT
Volume:5.32M
Turnover:523.51M
Market Cap:17.98B
PE:-16.77
High:99.65
Open:96.46
Low:96.01
Close:96.88
Loading ...

Insmed (INSM) Gets a Buy from Evercore ISI

TIPRANKS
·
01 May

Insmed Incorporated (INSM): Among Billionaire George Soros’ Mid-Cap Stocks With Huge Upside Potential

Insider Monkey
·
01 May

Insmed To Present at the BofA Securities 2025 Health Care Conference

PR Newswire
·
29 Apr

Top Analyst Reports for Microsoft, Broadcom & McDonald's

Zacks
·
29 Apr

Insmed to Redeem $569.5 Million of Convertible Senior Notes

MT Newswires Live
·
24 Apr

Insmed Announces Redemption of All $569.5 Million of Remaining Outstanding 0.75% Convertible Senior Notes Due 2028

THOMSON REUTERS
·
24 Apr

Insmed says NEJM publishes ‘positive’ results from Phase 3 ASPEN study

TIPRANKS
·
24 Apr

New England Journal of Medicine Publishes Positive Results from Insmed's Pivotal Phase 3 ASPEN Study of Brensocatib in Patients with Bronchiectasis

PR Newswire
·
24 Apr

Insmed Inc : Bofa Global Research Cuts Price Objective to $95 From $96

THOMSON REUTERS
·
23 Apr

Insmed to Host First-Quarter 2025 Financial Results Conference Call on Thursday, May 8, 2025

PR Newswire
·
23 Apr

Insmed Price Target Maintained With a $90.00/Share by HC Wainwright & Co.

Dow Jones
·
22 Apr

Insmed’s Brensocatib: A Promising Solution for Bronchiectasis in AATD Patients

TIPRANKS
·
22 Apr

Should iShares Morningstar Small-Cap ETF (ISCB) Be on Your Investing Radar?

Zacks
·
21 Apr

Insmed’s Chief Commercial Officer Resigns for Personal Reasons

TIPRANKS
·
18 Apr

Analysts Offer Insights on Healthcare Companies: Insmed (INSM), Community Health (CYH) and Argenx Se (ARGX)

TIPRANKS
·
11 Apr

Insmed (INSM) Gets a Buy from Mizuho Securities

TIPRANKS
·
09 Apr

Is Insmed Incorporated (INSM) the Best Long Term Growth Stock to Buy According to Billionaires?

Insider Monkey
·
09 Apr

Insmed participates in a conference call with Cantor Fitzgerald

TIPRANKS
·
08 Apr

RBC Capital Keeps Their Buy Rating on Insmed (INSM)

TIPRANKS
·
05 Apr

Insmed Incorporated (INSM): Insiders Were Dumping in Q1 2025

Insider Monkey
·
02 Apr